MiR-665 acts as a tumor-suppressive microRNA in neuroblastoma by directly targeting high mobility group box 1 (HMGB1) (activator of the Wnt/β-catenin pathway) and thus inactivating the Wnt/β-catenin pathway [38]. Here, HMGB1 is linked to neoplasm.